PerpEquities

Top analysts on stock perps · Analyst

David Nierengarten (Wedbush): analyst track record on stock perps

David Nierengarten of Wedbush on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.

Stars4.8★
Success45%
Excess return+15.7%
rank#588
Ratings480
ratings on stock perps42

Track record

TipRanks data via FMP

After buy calls: not enough measured cases yet

Current calls on stock perps

StockCallTargetvs last closeDate
$ARGX argenx SEBuy · Maintained$1,130+36.9%Oct 13, 2026
$ABVX Abivax S.A.Hold · Maintained$118+34.9%Sep 22, 2026

Recent ratings

  • Oct 13, 2026 $ARGX: Maintained · Buy · $1,130 · article
  • Sep 22, 2026 $ABVX: Maintained · Hold · $118 · article
  • Sep 3, 2026 $ARGX: Maintained · Buy · $1,150 · article
  • Aug 18, 2026 $ARGX: Maintained · Buy · $1,150 · article
  • Jul 28, 2026 $ARGX: Maintained · Buy · $1,050 · article
  • Jul 6, 2026 $ABVX: Maintained · Hold · $140 · article
  • Jun 30, 2026 $ABVX: Maintained · Hold · $110 · article
  • Jun 24, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Jun 2, 2026 $ABVX: Upgraded · Hold · $90.00 · article
  • May 21, 2026 $ABVX: Maintained · Sell · $110 · article
  • May 8, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Apr 23, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Apr 16, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Mar 18, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Mar 9, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Feb 24, 2026 $ABVX: Initiated · Sell · $110 · article
  • Jan 13, 2026 $ARGX: Maintained · Buy · $1,000 · article
  • Nov 14, 2025 $ARGX: Maintained · Buy · $1,000 · article
  • Oct 30, 2025 $ARGX: Maintained · Buy · $880 · article
  • Oct 13, 2025 $ARGX: Maintained · Buy · $880 · article

David Nierengarten4.8★ · 45% success · +15.7% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.